date,title,source
Oct-26-18,"Checkpoint Therapeutics, Inc. (CKPT) Q3 Earnings Preview: What to Watch Ahead of the Release",Zacks
Dec-25-18,"Are Checkpoint Therapeutics, Inc.s (NASDAQ:CKPT) Interest Costs Too High?",Simply Wall St.
Jan-07-19,Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301,GlobeNewswire
Mar-13-19,Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101,GlobeNewswire
